Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
newly diagnosed non-small cell lung cancer
|
3 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Papillary adenocarcinoma
|
3 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Primary Lesion
|
8 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Signs and Symptoms, Respiratory
|
10 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Neoplasms
|
1644 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 0.933 | 60 | 2009 | 2019 | ||||||
Malignant neoplasm of lung
|
1142 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 0.975 | 40 | 2005 | 2019 | ||||||
Carcinoma of lung
|
1204 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 0.968 | 31 | 2006 | 2019 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 0.968 | 31 | 2006 | 2019 | ||||||
Metastatic non-small cell lung cancer
|
11 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 1.000 | 12 | 2013 | 2019 | ||||||
Lung Neoplasms
|
39 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.060 | 1.000 | 6 | 2012 | 2019 | ||||||
Adenocarcinoma of lung, stage IV
|
6 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.040 | 1.000 | 4 | 2013 | 2019 | ||||||
Progressive cGVHD
|
40 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.040 | 1.000 | 4 | 2011 | 2019 | ||||||
Progressive Neoplastic Disease
|
40 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.040 | 1.000 | 4 | 2011 | 2019 | ||||||
Metastatic Malignant Neoplasm to the Leptomeninges
|
9 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
CNS metastases
|
14 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
HER2 gene amplification
|
14 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant neoplasm of stomach
|
615 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Stomach Carcinoma
|
652 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.800 | 0.983 | 176 | 2004 | 2020 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 1.000 | 58 | 2005 | 2020 | ||||||
Adenocarcinoma
|
168 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.100 | 0.941 | 34 | 2005 | 2020 | ||||||
Hyperplastic Polyp
|
22 | 0.570 | 0.560 | 7 | 55191822 | missense variant | TG/GT | mnv | 0.010 | 1.000 | 1 | 2020 | 2020 |